Nestle India faces FSSAI action over '5 HMOs', 'easy-to-digest' whey claims in baby food
- On Friday, the Food Safety and Standards Authority of India initiated legal action against Nestle India over alleged non-compliance involving its NAN Excella Pro Stage 1 and Lactogen Pro 1 infant nutrition products.
- According to FSSAI, both products violate Regulation 4 of the Food Safety and Standards Regulations, 2020. The regulator also cited Section 3 of the Infant Milk Substitutes, Feeding Bottles and Infant Foods Act, 1992, which prohibits their advertisement and promotion.
- FSSAI flagged promotional claims for NAN Excella Pro Stage 1 relating to "5 HMOs" and Whey Protein, while also questioning Lactogen Pro 1's claim that its Whey Protein was easy to digest.
- Separately, laboratory analysis found a follow-up formula manufactured by Nestle India did not conform to prescribed biotin requirements under the 2020 regulations. The sample was subsequently sent for re-analysis.
- Following the alleged violations, FSSAI filed 3 separate adjudication cases against Nestle India in relation to the products. The action covers promotional claim contraventions and laboratory findings concerning biotin content.
55 Articles
55 Articles
FSSAI action against Nestle India: Three cases filed over infant nutrition claims and biotin non-compliance
NEW DELHI: The Food Safety and Standards Authority of India (FSSAI) has initiated legal proceedings against Nestle India over multiple non-compliances under the FSS Act. Following the development, shares of the FMCG major fell marginally on September 18. FSSAI has filed three adjudication cases against Nestle India concerning three of its products. The products facing legal action are Infant Nutrition, NAN Excella and Lactogen. A sample of follo…
India finds Nestle baby food sample substandard, takes legal action
The scrutiny is the latest in a crackdown on India’s US$100 billion (S$127 billion) food industry which has included surprise factory visits and product testing.
FSSAI moves against Nestlé over baby formula claims and biotin test
Food regulator opens three cases over promotional claims on NAN Excella Pro and Lactogen Pro while a follow-up formula sample fails biotin tests; Nestlé says its products comply with regulations
Two DF babies are contaminated by Nestlé formula The food safety authority of India informed on Friday (18) that it found a Nestlé baby product out of the required standards in the country and opened an action against the Swiss company, one of its main growing markets. According to the Indian Food Safety and Standards Authority (FSSAI), a sample of a Nestlé infant formula presented a quantity of biotin, also known as vitamin B7, out of the param…
FSSAI begins legal action against Nestle India over baby food
New Delhi: Food regulator FSSAI on Friday, September 18, said it has initiated legal action against Nestle India for alleged violations of rules in three infant nutrition products, but the FMCG major asserted that it was ‘fully compliant’ with applicable regulations. The legal action has been initiated with respect to NAN Excella Pro Stage 1, … Get the latest updates in Hyderabad City News, Technology, Entertainment, Sports, Politics and Top Sto…
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



























